|
JAK1/2 inhibitor ruxolitinib for the treatment of systemic chronic active Epstein-Barr virus disease: a phase 2 study |
|
|
|
Titel: |
JAK1/2 inhibitor ruxolitinib for the treatment of systemic chronic active Epstein-Barr virus disease: a phase 2 study |
Auteur: |
Uemura, Yu Yamamoto, Masahide Ishimura, Masataka Kanegane, Hirokazu Sawada, Akihisa Hirakawa, Akihiro Imadome, Ken-Ichi Yoshimori, Mayumi Nagata, Masashi Yamamoto, Kouhei Shimizu, Norio Koike, Ryuji Arai, Ayako |
Verschenen in: |
Blood neoplasia |
Paginering: |
Jaargang 2 () nr. 1 pagina's p. |
Jaar: |
2025 |
Inhoud: |
|
Uitgever: |
The American Society of Hematology |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|